Century Therapeutics (IPSC) Other financing activities (2020 - 2026)

Century Therapeutics (IPSC) reported Other financing activities of -$20000.0 for Q1 2026, down 200.0% quarter-over-quarter from $20000.0 in Q1 2024.

Century Therapeutics (IPSC) Other financing activities (2020 - 2026) Analysis & Trends

Century Therapeutics (IPSC) has 4 years of Other financing activities data on file, last reported at -$20000.0 in Q1 2026.

Other financing activities for Q1 2026 came in at -$20000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $20000.0 (changed N/A YoY), and the FY2021 annual result was $31.9 million, down 57.38% from the prior year.
Other financing activities eased to -$20000.0 in Q1 2026 per IPSC's latest filing, from $20000.0 in the prior quarter.
Over five years, Other financing activities peaked at $20000.0 in Q1 2024 and troughed at -$20000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Century Therapeutics	444.99 Mn	444.99 Mn	-

Download Data